Cognitive performance by humans during a smoked cocaine binge-abstinence cycle

American Journal of Drug and Alcohol Abuse

Volumn 31, Issue 4, 2005, Pages 571-591

  Pace Schott, Edward F ^a,d   Stickgold, Robert ^a   Muzur, Amir ^a   Wigren, Pia E ^b   Ward, Amie S ^b   Hart, Carl L ^b   Walker, Matthew ^a   Edgar, Chris ^c   Hobson, J Allan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c Cognitive Drug Research Ltd ^*  (United Kingdom)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Abstinence; Attention; Binge; Cocaine; Cognition; Memory; Repeated assessments

Indexed keywords

COCAINE; SMOKED COCAINE; UNCLASSIFIED DRUG;

ADULT; ALERTNESS; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITION; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; REACTION TIME; RECOGNITION; SLEEP; TASK PERFORMANCE; WORKING MEMORY;

ADULT; CHRONIC DISEASE; CIRCADIAN RHYTHM; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 27944437378     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-200068120     Document Type: Article

References (57)

1. Bolla KI, Funderburk FR, Cadet J-L. Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 2000; 54:2285-2292.
2. Bolla KI, Rothman R, Cadet J-L. Dose related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1999; 11:361-369.
3. Di Sclafani V, Tolou-Shams M, Price LJ, Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002; 66:161-171.
4. Fein G, Di Sclafani V, Meyerhoff D. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend 2002; 68:87-93.
5. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159:1642-1652.
6. Horner MD. Attentional functioning in abstinent cocaine abusers. Drug Alcohol Depend 1999; 54:19-33.
7. Robinson JE, Heaton RK, O'Malley SS. Neuropsychological functioning in cocaine abusers with and without alcohol dependence. Int Neuropsychol Soc 1999; 5:10-19.
8. Rosselli M, Ardila A, Lubomski M, Murray S, King K. Personality profile and neuropsychological test performance in chronic cocaine-abusers. Int J Neurosci 2001; 110:55-72.
9. Toomey R, Lyons MJ, Eisen SA, Xian H, Chantarujikapong S, Seidman LJ, Faraone SV, Tsuang MT. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry 2003; 60:303-310.
10. Bauer LO. Psychomotor and electroencephalographic sequelae of cocaine dependence. NIDA Res Monogr 1996; 163:66-93.
11. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ. Neuropsychological performance of recently abstinent alcoholic and cocaine abusers. Drug Alcohol Depend 1995; 37:247-253.
12. Bolla KI, Cadet J-L, London ED. The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci 1998; 10:280-289.
13. Hoff AI, Riordan H, Morris L, Cestaro V, Weineke M, Alpert R, Wang GJ, Volkow ND. Effects of crack cocaine on neurocognitive function. Psychiatry Res 1996; 60:167-176.
14. Roberts LA, Bauer LO. Reaction time during cocaine versus alcohol withdrawal: longitudinal measures of visual and auditory suppression. Psychiatry Res 1993; 46:137-229.
15. Rosselli M, Ardila A. Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol 1996; 18:122-135.
16. Foltin RW, Fischman MW. A laboratory model of cocaine withdrawal in humans: intravenous cocaine. Exp Clin Psychopharmacol 1997; 5:404-411.
17. Ward AS, Haney M, Fischman MW, Foltin RW. Binge cocaine self-administration by humans: smoked cocaine. Behav Pharmacol 1997; 8(8):736-744.
18. Ward AS, Haney M, Fischman MW, Foltin RW. Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berl) 1997; 132(4):375-381.
19. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle aged volunteers. Psychopharmacology (Berlin) 2000; 152:353-361.
20. Wesnes KA, Garratt C, Wickens M, Gudgeon A, Oliver S. Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers. Br J Clin Pharmacol 2000; 49(2):110-117.
21. Pincock C, Davies G, Wesnes KA. The effects of training on the quality of performance on computerised cognitive tasks. J Psychopharmacol 1997; 11(Supplement):A57.
22. Wesnes K, Lockton A, Rolan P, Stephenson N, Pincock C. Volunteer study of the potential interaction between remacemide 300 mg and alcohol (0.7 g/kg). J Psychopharmacol 1997; 11(Supplement):A59.
23. Wesnes KA, Ward T. Training effects on tests of cognitive function, and the implications for clinical trials. J Psychopharmacol 2000; 14(Supplement):A47.
24. Wesnes K, Beuzen J-N, Taylor N, Wood A. The effects of olanzapine and haloperidol on cognitive function in healthy elderly volunteers. J Psychopharmacol 1997; 11(Supplement):A75.
25. Wesnes K, Pincock C. Practice effects on cognitive tasks: a major problem? Lancet Neurol 2002; 1(8):473.
26. Pace-Schott EF, Stickgold R, Muzur A, Wigren P, Ward AS, Hart C, Clarke D, Fischman MW, Hobson JA. Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacology 2005; 179:873-883.
27. Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD. Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 1990; 26(2):145-154.
28. Zar JH. Biostatistical Analysis. 2nd ed. Englewood Cliffs: Prentice Hall, 1984.
29. Lipsey MW, Wilson DB. Practical Meta-Analysis. Thousand Oaks, CA: Sage Publications, 2000.
30. Bauer LO. Vigilance in recovering cocaine-dependent and alcohol-dependent patients: a prospective study. Addict Behav 1994; 19:599-607.
31. Bondi MW, Drake AI, Grant I. Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse. J Int Neuropsychol Soc 1998; 4(4):319-328.
32. O'Malley S, Adamse M, Heaton R, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am Drug Alcohol Abuse 1992; 18:131-144.
33. Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM, Satz P, Meyers H. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1993; 5:419-427.
34. Easton C, Bauer LO. Neuropsychological correlates of urine toxicology results. Prog Neuro-Psychopharmacol Biol Psychiatry 1996; 20(6):969-982.
35. Lavie P. The 24-hour sleep propensity function: practical and theoretical implications. In: Monk TH, ed. Sleep, Sleepiness and Performance. Chichester. John Wiley & Sons, Ltd., 1991:65-93.
36. Roberts DC, Brebner K, Vincler M, Lynch WJ. Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend 2002; 67(3):291-299.
37. Erickson TB, Lee J, Zautcke JL, Morris R. Analysis of cocaine chronotoxicology in an urban ED. Am J Emerg Med 1998; 16(6):568-571.
38. Giorgetti M, Zhdanova IV. Chronic cocaine treatment induces dysregulation in the circadian pattern of rats' feeding behavior. Brain Res 2000; 877(2):170-175.
39. Johanson CE, Roehrs T, Schuh K, Warbasse L. The effects of cocaine on mood and sleep in cocaine dependent males. Exp Clin Psychopharmacol 1999; 7:338-346.
40. Kowatch RA, Schnoll SS, Knisely JS, Green D, Elswick RK. Electroencephalographic sleep and mood during cocaine withdrawal. J Addict Dis 1992; 11:21-45.
41. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26(2):117-126.
42. Harrison Y, Horne JA. The impact of sleep deprivation on decision making: a review. J Exp Psychol, Appl 2000; 6(3):236-249.
43. Maquet P, Smith C, Stickgold R, eds. Sleep and Plasticity. New York: Oxford University Press, 2003.
44. Bradberry CW. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci 2000; 20(18):7109-7115.
45. Baumann MH, Becketts KM, Rothman RB. Evidence for alterations in presynaptic serotonergic function during withdrawal from chronic cocaine in rats. Eur J Pharmacol 1995; 282(1-3):87-93.
46. Belej T, Manji D, Sioutis S, Barros HM, Nobrega JN. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects. Brain Res 1996; 736(1-2):287-296.
47. Wilson JM, Carroll ME, Lac ST, DiStefano LM, Kish SJ. Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine. Neurosci Lett 1994; 180(1):29-32.
48. Kalivas PW, McFarland K, Bowers S, Szumlinski K, Xi ZX, Baker D. Glutamate transmission and addiction to cocaine. Ann NY Acad Sci 2003; 1003:169-175.
49. Xi ZX, Ramamoorthy S, Shen H, Lake R, Samuvel DJ, Kalivas PW. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci 2003; 23(8):3498-3505.
50. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14(2):169-177.
51. Fleckenstein AE, Gibb JW, Hanson GR. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol 2000; 406:1-13.
52. Staley JK, Talbot JZ, Ciliax BJ, Miller GW, Levey AI, Kung MP, Kung HF, Mash DC. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. Brain Res 1997; 747(2):219-229.
53. Kish SJ, Kalasinsky KS, Furukawa Y, Guttman M, Ang L, Li L, Adams V, Reiber G, Anthony RA, Anderson W, Smialek J, DiStefano L. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Mol Psychiatry 1999; 4(1):26-32.
54. Pace-Schott EF, Morgan P, Edgar C, Malison RT, Hart CL, Walker M, Hobson JA, Stickgold R. Cocaine users differ from normals on cognitive tasks which show declining performance during drug abstinence. Sleep 2004; 27(Supplement):A346.
55. Jones S, Jensen NO, Oliver S, Wesnes KA. First in man cognitive effects of NS2330, a novel monoamine reuptake inhibitor, in volunteers. J Psychopharmacol 1999; 13(Supplement):A26.
56. Teichner G, Homer MD, Harvey RT. Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int Neurosci 2001; 106:253-263.
57. Teichner G, Homer MD, Roitzsch JC, Herron J, Thevos A. Substance abuse treatment outcomes for cognitively impaired and intact out-patients. Addict Behav 2002; 27:751-763.